Video

Dr. Barrientos on Important Considerations for Patients with MCL

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses important considerations for patients with mantle cell lymphoma.

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses important considerations for patients with mantle cell lymphoma (MCL).

First, a patient with MCL should consider a second opinion when they are not responding well to treatment. Centers that specifically treat patients with MCL could have certain access to clinical trials that may not yet be available to community oncologists. Enrolling in a clinical trial could improve survival outcomes. Patients should at least speak with an expert if they are exhausting their treatment options.

Barrientos adds that the Leukemia & Lymphoma Society also has access to ongoing clinical trials testing promising agents. The biggest challenge for patients with MCL is the high risk of relapse. A recently published clinical trial tested ibrutinib (Imbruvica) with venetoclax (Venclexta), and showed promising responses in this setting. Great activity is being seen with novel therapies, Barrientos says, and it could change the management of MCL as long as toxicity is manageable.

Related Videos
C. Ola Landgren, MD, PhD
Sara M. Tolaney, MD, MPH
Adam M. Brufsky, MD, PhD, FACP
Justin M. Watts, MD
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Chirag Shah, MD
Jason A. Mouabbi, MD
Roger Li, MD,